Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

604 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identifying Factors Associated with the Efficacy of Lasmiditan 50 mg as an Acute Treatment for Migraine Attacks Under Various Dosing Conditions in Real-World Clinical Practice.
Tanei T, Yamamoto S, Maesawa S, Nishimura Y, Ishizaki T, Nagashima Y, Ito Y, Hashida M, Suzuki T, Hamasaki H, Wakabayashi T, Saito R. Tanei T, et al. Among authors: hashida m. Neurol Int. 2025 Apr 22;17(5):62. doi: 10.3390/neurolint17050062. Neurol Int. 2025. PMID: 40423218 Free PMC article.
Outcomes and Prognostic Factors of Magnetic Resonance-guided Focused Ultrasound Thalamotomy for Essential Tremor at 2-year Follow-up.
Hashida M, Maesawa S, Kato S, Nakatsubo D, Tsugawa T, Torii J, Tanei T, Ishizaki T, Mutoh M, Ito Y, Tsuboi T, Mizuno S, Suzuki M, Wakabayashi T, Katsuno M, Saito R. Hashida M, et al. Neurol Med Chir (Tokyo). 2024 Apr 15;64(4):137-146. doi: 10.2176/jns-nmc.2023-0202. Epub 2024 Feb 15. Neurol Med Chir (Tokyo). 2024. PMID: 38355128 Free PMC article.
Comparison of Early-onset Efficacy of Anti-calcitonin Gene-related Peptide Monoclonal Antibodies for Patients with Migraine in Real-world Clinical Practice: Study Protocol for an Exploratory Clinical Trial.
Tanei T, Maesawa S, Nishimura Y, Ishizaki T, Nagashima Y, Hashida M, Yamamoto S, Ando M, Kuwatsuka Y, Hashizume A, Wakabayashi T, Saito R. Tanei T, et al. Among authors: hashida m. Neurol Med Chir (Tokyo). 2025 Feb 15;65(2):71-80. doi: 10.2176/jns-nmc.2024-0201. Epub 2024 Dec 10. Neurol Med Chir (Tokyo). 2025. PMID: 39662907 Free PMC article.
Evaluation of mild cognitive impairment in older patients with essential tremor.
Hashida M, Maesawa S, Mizuno S, Kato S, Ito Y, Mutoh M, Suzuki T, Ishizaki T, Tanei T, Tsuboi T, Suzuki M, Nakatsubo D, Tsugawa T, Bagarinao E, Wakabayashi T, Katsuno M, Saito R. Hashida M, et al. Parkinsonism Relat Disord. 2025 Feb;131:107228. doi: 10.1016/j.parkreldis.2024.107228. Epub 2024 Dec 9. Parkinsonism Relat Disord. 2025. PMID: 39673860
Real-world clinical results of CGRP monoclonal antibody treatment for medication overuse headache of migraine without abrupt drug discontinuation and no hospitalization.
Tanei T, Fuse Y, Maesawa S, Nishimura Y, Ishizaki T, Nagashima Y, Mutoh M, Ito Y, Hashida M, Suzuki T, Yamamoto S, Wakabayashi T, Saito R. Tanei T, et al. Among authors: hashida m. Heliyon. 2024 Nov 6;10(22):e40190. doi: 10.1016/j.heliyon.2024.e40190. eCollection 2024 Nov 30. Heliyon. 2024. PMID: 39748981 Free PMC article.
604 results